Part of The Feinstein Institute for Medical Research, the Chronic Lymphocytic Leukemia Research and Treatment Program offers a unique environment where CLL researchers and clinicians work together to develop the best evidence-based treatment. The program, headed by Nicholas Chiorazzi, MD, and Kanti Rai, MD (a pioneer in CLL research for more than 40 years) currently offers more than a dozen clinical drug trials that are being tested against the disease.

Funding Future Research

  • Investigate developing a drug regimen including drugs that kill CLL cells at the time of birth as well as when they are mature (as is the current approach)
  • Take advantage of understanding the common shape of antibodies in CLL in order to make drugs directed at those common shapes.
  • Develop therapies that block interaction of CLL cells with the internal enviornment of our bodies, building on multiple findings over the past 3 decades.

For more information about The CLL Research Treatment Program Click Here

 
Donation Information
$ 5,000.00
$ 2,500.00
$ 1,000.00
$ 500.00
$ 250.00
$ 100.00
$    
Additional Information
Billing Information
*
*
*
*
*
*
*
*
*
*
Payment Information
*
*
  *
*
help *
Matching Gifts
Support/Honor/Memorial Gifts

* Please do not click Donate Now twice.
Processing may take a few minutes.
Thank you for your patience.